EGFR and ovarian carcinoma: Similar results with higher variances (possibly due to the smaller size of the datasets) can be observed for EGFR amplifications in glioblastoma (Figure S6) and LUSC (Figure S7), for PVT1 amplifications in ovarian cancer (Figure S8) and for PTEN deletions in sarcoma (Figure S9).